Each Medicaid managed care organization, in consultation with the organization’s provider advisory group required by contract, shall develop and implement a process to conduct an annual review of the organization’s prior authorization requirements, other than a prior authorization requirement prescribed by or implemented under Section 531.073 for the vendor drug program.